nach oben

World Journal of Surgical Oncology

Erschienen in:

Open Access 01.12.2023 | Research

Caprini risk assessment model combined with D-dimer to predict the occurrence of deep vein thrombosis and guide intervention after laparoscopic radical resection of colorectal cancer

verfasst von: Wuming Zhang, Ruizheng Sun, Xianqin Hu, Zhikang Chen, Chen Lai

Erschienen in: World Journal of Surgical Oncology | Ausgabe 1/2023

Abstract

Background

To explore the diagnostic value of Caprini risk assessment model (2005) combined with D-dimer for deep vein thrombosis, and to exclude patients with low incidence of thrombosis who might not need anticoagulation after surgery.

Methods

A total of 171 colorectal cancer patients who underwent surgery from January 2022 to August 2022 were enrolled in this study. Caprini risk assessment model was used to evaluate patients the day before surgery, and full-length venous ultrasonography of lower extremity was used to assess whether patients had thrombosis one day before surgery and the sixth day after surgery. The value of D-dimer was measured by enzyme-linked immunosorbent assays on the first day after surgery, and clinical data of patients were collected during hospitalization.

Results

A total of 171 patients were divided into IPC Group and IPC + LMWH Group according to whether low molecular weight heparin (LMWH) were used to prevent thrombus after surgery. Eventually, 17.6% (15/85) patients in IPC Group and 7% (6/86) patients in IPC + LMWH Group developed DVT. Through separate analysis of IPC Group, it is found that Caprini score and D-dimer were independent risk factors for DVT (Caprini OR 3.39 [95% CI 1.38–8.32]; P = 0.008, D-Dimer OR 6.142 [95% CI 1.209–31.187]; P = 0.029). The area under ROC curve of Caprini risk assessment model is 0.792 (95% CI 0.69–0.945, P < 0.01), the cut-off value is 9.5, and the area under ROC curve of D-dimer is 0.738 (95%CI 0.555–0.921, P < 0.01), the cut-off value is 0.835 μg/mL, and the area under the ROC curve was 0.865 (95% CI 0.754–0.976, P < 0.01) when both of them were combined. Based on decision curve analysis, it is found that Caprini risk assessment model combined with D-dimer can benefit patients more. All patients are divided into four groups. When Caprini score < 10 and D-dimer < 0.835 μg/mL, only 1.23% (1/81) of patients have thrombosis and LMWH has little significance. When Caprini score > 10 and D-dimer > 0.835 μg/mL, the incidence of DVT is 38.7% (12/31) and LMWH should be considered.

Conclusions

The Caprini risk assessment model and D-dimer can provide more accurate risk stratification for patients after laparoscopic radical resection of colorectal cancer.

Wuming Zhang and Ruizheng Sun made equal contributions to this work.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

DVT

Deep vein thrombosis

IPC

Intermittent pneumatic compression

LMWH

Low molecular weight heparin

ACU

Area under curve

ROC

Receiver operating characteristic curve

Background

Colorectal cancer is one of the most common malignant tumors worldwide, accounting for the third highest incidence and mortality of malignant tumors [1]. Laparoscopic surgery is currently the primary treatment for colorectal cancer and can considerably improve the prognosis of patients. Deep vein thrombosis (DVT) is a common postoperative complication in patients with colorectal cancer and a great burden on medical resources worldwide [2]. Postoperative DVT of patients with CRC has been a nonnegligible problem. The incidence of DVT after colorectal surgery is as high as 40% without prevention, and the main causes include advanced age, malignant tumors, major surgery, and bedridden [3].

At present, the main standpoint is to reduce the occurrence of DVT by effective prevention. A Japanese study on postoperative venous thromboembolism in patients with abdominal tumors found that the incidence of venous thromboembolism after intermittent pneumatic compression (IPC) prevention was 19.4% and that of thrombosis after enoxaparin prevention was 1.2%. Therefore, accurate evaluation and prompt interventions are important for reducing DVT [4].

The Caprini risk assessment model (2005) has been verified and is currently the most widely used model in surgery [5]. The American College of Chest Physicians guidelines recommend that abdominal surgery should be stratified through the Caprini risk assessment model and that mechanical prophylaxis should be combined with drug prophylaxis for high-risk patients (Caprini score ≥ 5) [6]. All patients with colorectal cancer who are stratified according to the Caprini risk assessment model are supposed to be at high risk postoperatively. The Caprini risk model might not solely be an accurate indicator for DVT occurrence and intervention in colorectal cancer.

D-dimer is a biomarker of fibrin formation and degradation and acts a marker of coagulation and fibrinolysis system activation. As an indirect marker of thrombosis activity, D-dimer is of great significance for checking the formation of acute venous thrombosis [7]. Although D-dimer has high negative predictive value for DVT, it has low positive predictive value and low specificity for thrombosis [8, 9]. We hope to re-stratify patients with colorectal cancer through the Caprini risk assessment model and postoperative D-dimer levels, thereby identifying people at high risk of thrombosis from patients with colorectal cancer and further guiding postoperative thrombus prevention strategies for these patients.

Materials and methods

Patients and design

Prospectively collect patients’ clinical data generated undergoing laparoscopic radical resection of colorectal cancer in department of Colorectal and Anal Surgery, Xiangya Hospital, Central South University from January 2022 to August 2022. The patients will be jointly assessed by two professionally trained doctors using Caprini risk assessment model one day before the surgery. The aim of study was to assess whether the patients had venous thrombosis by color Doppler ultrasonography of both lower extremity veins on day 6 (± 1) after surgery. This study was retrospective and did not intervene in the treatment process, approved by the Ethics Committee of Xiangya Hospital, Central South University Hospital (No. 202112186).

The inclusion criteria include.

(1)

Patients with informed consent.

(2)

Postoperative pathology examination confirmed colorectal cancer.

(3)

Patients undergoing elective laparoscopic radical resection of colorectal cancer.

The exclusion criteria include.

(1)

Patients who require the informed consent to be returned.

(2)

Patients who did not have color Doppler ultrasonography.

Data collection

The basic information about patients was collected through the case system, such as sex and age. The following clinical information was collected: operation time, intraoperative blood loss, hospitalization days, body mass index, preoperative chemotherapy, preoperative intestinal obstruction, white blood cell count on admission, hemoglobin on admission, D-dimer on the first day postoperatively, color Doppler ultrasonic of veins of both lower extremities preoperatively, color Doppler ultrasonic of veins of both lower extremities on the sixth day postoperatively, results of the pathological examination, use of anticoagulants, and Caprini score. The cut-off of D-dimer was calculated based on ROC curves of the IPC group. The Youden index reached max when the cutoff of D-dimer was 0.835 μg/mL.

Data analysis

SPSS (Version 26), GraphPad Prism (Version 8.0), and R (Version 4.0) were used for retrospective analysis. Analytical method for describing data and differential analysis depended on the data type. First, the normality test was conducted, the measurement data of normality were tested using independent sample T-test, the non-normal measurement data were tested using the Mann–Whitney U test, and the data were expressed by x ± s or M (P25–P75). The counting data were measured by the chi-square test and Fisher's exact test and expressed as percentages. Differential factors between patients with or without DVT in the IPC group were considered significant factors for DVT. P < 0.05 were considered significant. The power of statistic in this study was not calculated because the effect size was not previously confirmed. These significant factors were then fitted in the multivariate regression model to evaluate independence. Simultaneously, the receiver operating characteristic curves (ROC) were obtained to evaluate the applicability of the Caprini risk assessment model and D-dimer. The potential net benefit of different intervention thresholds based on predictive models was evaluated using the decision curve analysis (DCA). Construction and visualization of DCA were achieved in the R statistics environment with the guide of MSKCC (https://www.mskcc.org/departments/epidemiology-biostatistics/biostatistics/decision-curve-analysis).

Results

Basic data

The clinical data of 186 patients were collected, of which 171 patients were included and 15 patients excluded. The reasons for exclusion were as follows: 6 patients had a color Doppler ultrasound of lower extremity venous showing thrombosis preoperatively and nine patients had no preoperative or postoperative color Doppler ultrasound of lower extremity venous. Furthermore, 85 (49.4%) patients did not have a prophylactic use of anticoagulants, and 86 (50.6%) patients used of low molecular weight heparin (LMWH) to prevent thrombosis from the first day postoperatively (nadroparin 4100 IU, once a day) till discharge. If there was massive hemorrhage and the platelet count was < 60 × 10¹², the anticoagulants were stopped. All patients were treated with IPC (twice a day, 20 min each time) to improve venous reflux and prevent venous thrombosis of the lower extremities (Table 1). In this way, patients were stratified into two groups, the IPC group and the IPC + LMWH group (Fig. 1).

Table 1

Patient baseline characteristics table

Subjects		IPC group	IPC + LMWH group	P value
Age		58.88(± 8.93)	60.93(± 10.07)	0.162
Sex	Man	48	54	0.4
Sex	Woman	37	32
Pre-operative chemotherapy	No	70	63	0.153
Pre-operative chemotherapy	Yes	15	23
Incomplete intestinal obstruction	No	80	78	0.399
Incomplete intestinal obstruction	Yes	5	8
Pelvic operation	No	44	47	0.705
Pelvic operation	Yes	41	39
Postoperative hospital stays (day)		6 (5.5–7)	6 (6–8)	0.281
BMI		23.80 (21.3–25.7)	23.16 (21.0–25.0)	0.814
Caprini score		8.95(± 1.0)	9.45(± 1.37)	0.011
Operation time (min)		190 (152–240)	190 (168–230)	0.408
Intraoperative blood loss (mL)		50 (25–50)	50 (30–50)	0.606
Diameter of tumor (cm)		4 (2.5–5)	4 (3–5)	0.034
WBC (× 10^Λ9/L)		5.1 (4.05–6.4)	4.9 (3.9–6)	0.203
HB (g/L)		125 (110.5–141)	120.5 (120.5–130)	0.076
PLA (× 10^Λ9/L)		220 (173.5–268)	206.5 (164.5–259.75)	0.17
D-dimer (μg/mL)		0.51 (0.315–0.855)	0.755 (0.467–1.175)	0.003

In total, 21 patients developed DVT, including 17.6% (15/85) in the IPC group and 7% (6/86) in the IPC + LMWH group. The incidence of DVT in IPC + LMWH was significantly lower than IPC group (P = 0.038). All thrombosis occurred in the distal veins of the lower extremities but none in the proximal veins; all venous thromboses of the lower extremities were asymptomatic.

Caprini risk assessment and D-dimer test were independent risk factors for DVT in the IPC group

To exclude the effect of LWMH, differential analyses were conducted between patients with or without DVT in the IPC group. The results revealed that a D-dimer level of > 0.835 μg/mL, Caprini score, tumor diameter, preoperative hemoglobin level, preoperative platelet count, and incomplete intestinal obstruction preoperatively were potentially risk factors for postoperative thrombosis (Table 2).

Table 2

Single-factor analysis of deep vein thrombosis incidence risk in IPC group

Thrombus occurrence
Subjects	No	Yes	P value
Sex
Male	41	7	0.399
Female	29	8
Pre-operative chemotherapy
No	56	14	0.289
Yes	14	1
Incomplete intestinal obstruction
No	68	12	0.037
Yes	2	3
D-dimer (μg/mL)
< 0.835	58	4	< 0.01
> 0.835	12	11
Pelvic operation
No	34	10	0.203
Yes	36	5
Age	57 (52–60.5)	67 (61–80)	< 0.01
BMI	23.8 (23.6–25.5)	24.0 (19.5–29.5)	0.708
Postoperative hospital stays (day)	6 (5.75–7)	6 (5–9)	0.365
Caprini score	9 (8–9)	10 (10–11)	< 0.01
Operation time	195 (158–240)	180 (145–260)	0.782
Intraoperative blood loss	50 (27.5–50)	50 (20–100)	0.57
Diameter of tumor	3.55 (2.48–4.55)	4.5 (4–7)	0.014
WBC × 10^Λ9/L	5.2 (4.1–6.45)	4.6 (3.5–5.5)	0.271
HB g/L	128 (114–142)	110 (81–127)	0.014
PLA × 10^Λ9/L	215.5 (166–254)	240 (201–314)	0.08

The Caprini score was included and age was excluded in binary logistics regression due to the linear relationship between age and the Caprini score. Preoperative hemoglobin level, preoperative platelet count, tumor diameter, a D-dimer level of > 0.835 μg/mL, and obstruction were included in multivariate analysis. The results showed that D-dimer (P = 0.029, OR = 6.142, CI (1.209–31.187)) and Caprini score (P < 0.01, OR = 3.39, CI (1.38–8.32) were the independent influencing factors of postoperative thrombosis. The incidence of DVT with a D-dimer level of > 0.835 was 6.142 times higher than that of a D-dimer level of < 0.835 μg/mL. The incidence of DVT increased by 3.39 times when the Caprini score increased by one point (Table 3).

Table 3

Logistic regression analysis of deep vein thrombosis risk factors

Risk factor	P	OR	95%CI
Caprini score	0.008	3.39	1.38	8.32
D-dimer	0.029	6.142	1.209	31.187
Preoperative platelet	0.450	1.004	0.994	1.014
Preoperative hemoglobin	0.273	0.983	0.953	1.014
Tumor diameter	0.321	1.256	0.801	1.970
Intestinal obstruction	0.227	0.207	0.016	2.660
Constant	0.057	0

Models based on Caprini risk assessment and D-dimer showed great discrimination of DVT in the IPC group

In the IPC group, ROC based on Caprini risk assessment or D-dimer revealed considerable predictive ability of DVT. Area under curve (AUC) of the Caprini model was 0.792 (95% confidence interval (CI) 0.69–0.945, P < 0.01), the cutoff value was 9.5, the sensitivity was 80%, and the specificity was 84.3% (Fig. 2). The AUC of D-dimer was 0.738 (95% CI 0.555–0.921, P < 0.01), the cutoff value was 0.835 μg/mL, the sensitivity was 73.3%, and the specificity was 82.9% (Fig. 2).

We then integrated Caprini score as a continuity variable and D-dimer as a binary variable into a novel predictive model according to the results of multivariate logistic regression model. A new ROC curve based on Caprini score and D-dimer was obtained. The AUC was 0.865 (95% CI 0.754–0.976), the sensitivity was 93.3%, and the specificity was 73.9% (Fig. 3). The Caprini score combined with the D-dimer level was a better predictor of postoperative DVT than the Caprini score or D-dimer alone in patients with colorectal cancer.

The model based on Caprini score and D-dimer was reliable in the whole cohort

We then observed the predictive robustness of Caprini score and D-dimer. The Caprini score and anticoagulants were used to predict the occurrence of postoperative DVT in the whole population. The AUC was 0.750 (95% CI 0.632–0.868, P < 0.01). After adding D-dimer in the model, the AUC reached 0.845 (95% CI 0.754–0.936, P < 0.01), indicating that the Caprini score combined with the D-dimer still had promising predictive efficiency in the whole population (Fig. 4).

Clinical decisions based on the model of Caprini score and D-dimer might benefit for patients

The R language was used to make the decision curve model, with the threshold probability as Abscissa and benefit degree as ordinate [10]. Although the benefit degree of the Caprini score combined with the D-dimer level was between 21 and 27%, it was lower than that of the Caprini score alone; however, the overall trend was better than that of the Caprini score, particularly in the range of 16% of the first 5% of the curve, the benefit degree was much higher than that of the Caprini score alone. Concurrently, these two curves were above all the patients who received the intervention (Fig. 5).

Then, to facilitate potential clinical application, we divided the patients into four groups according to the boundary of a Caprini score of 9.5 and a D-dimer level of 0.835 μg/mL. The Caprini score could only be an integer; thus, we used a threshold of 10. The results revealed that patients with Caprini score < 10 and D-dimer < 0.835 have a very low probability (1.23%) of deep vein thrombosis. The incidence of DVT rose accompanied with increased Caprini score or elevated D-dimer. Patients with Caprini score > 10 and D-Dimer > 0.835 had the highest rate (38.7%) of DVT occurrence (Fig. 6). The incidence of DVT in the IPC + LMWH group was significantly lower than that in the IPC group for patients with Caprini score > 10 and D-dimer > 0.835 (16.7% vs 69.2%, P = 0.008).

Discussion

Accurate recognition and prompt intervention are crucial for DVT prevention in perioperative patients with colorectal cancer. Our results confirmed that Caprini score and D-dimer were both independent risk factors for DVT. Combination of Caprini score and D-dimer had superior predictive ability than Caprini score or D-dimer alone. The incidence of thrombosis is very low in patients with a Caprini score of < 10 and a D-dimer level of < 0.835 μg/mL. Patients with higher Caprini scores and elevated D-dimer levels are most likely to develop DVT postoperatively. Anticoagulants should be strongly recommended during hospitalization for patients with a Caprini score ≥ 10 or a D-dimer > 0.835 μg/mL.

The applicability of the Caprini score in patients with colorectal cancer has been verified by predecessors. The AUC of lower extremity venous thrombosis predicted by the Caprini score in all patients with colorectal cancer was 0.701 [11]. We reached a similar conclusion that the AUC was 0.732 (95% CI 0.613–0.85) in all patients. In addition, we noted that the AUC was 0.792 (95% CI 0.639–0.945) in the IPC group and the Caprini score was moderately effective in patients with colorectal cancer. The positive predictive value of Caprini score in the IPC group was 52.2%, while adding D-dimer in the model improved the positive predictive value to 69.2%. Further studies are needed to further improve the applicability of Caprini risk assessment model.

The cutoff of Caprini score for patients with colorectal cancer might also need further discussions and investigations. In our study, all patients with colorectal cancer had a postoperative Caprini score of > 5, which meant that all patients needed postoperative anticoagulants. In fact, prophylactic anticoagulants have no significant effect on the occurrence of pulmonary embolism and proximal venous thrombosis of lower extremities (IPC vs. IPC + anticoagulant therapy = 5.1% vs. 2.76%, P = 0.382) [12]. Simultaneously, a previous meta-analysis of abdominal surgery found that it was important to use anticoagulants to prevent venous thrombosis in patients with a perioperative Caprini score of ≥ 7 score, whereas it was not required in patients with a Caprini score < 7, and it was recommended to further screen high-risk patients by increasing the threshold of the Caprini score [13]. It is possible to more accurately guide the use of postoperative anticoagulants in patients with colorectal cancer by adjusting the threshold of Caprini scores or by introducing new indicators.

D-dimer level tested by the enzyme-linked immunosorbent assays method has high sensitivity (95%) but low specificity (40%) when the cutoff value is 0.5 μg/mL [7]. In the IPC group, the positive and negative predictive value of D-dimer was 47.8% and 93.5%, correspondingly. It meant that elevated D-dimer level might not indicate incidence of DVT, while patients with D-dimer < 0.835 μg/mL could exclude possibility of DVT, At present, patients with colorectal cancer and lower postoperative D-dimer level should be considered low risk individuals for venous thrombosis [14]. In our study, we used D-dimer level on the first day after surgery as an indicator. Postoperative measurement of D-dimer before the use of anticoagulant drugs did not affect the course of anticoagulant therapy, but reflected the coagulation status of patients after surgery. There were 81 patients with Caprini score < 10 and D-dimer < 0.835 μg/mL, of which only one patient (1.23%) developed a DVT postoperatively, whereas the incidence of thrombus was higher in other groups. According to ACCP guideline, IPC is the best prophylaxis measure for patients with a low risk of venous thrombosis (< 1.5%) [6]. Preoperative use of anticoagulant drugs increased the risk of intraoperative and postoperative bleeding, but could not reduce the occurrence of postoperative thrombosis [15‐17]. The application of LMWH could increase the incidence of clinical-related bleeding to 11.5% (60/524) [18]. Taking potential bleeding risk of LMWH into consideration, we do not recommend preventive prophylactic anticoagulants for these patients with colorectal cancer.

By introducing D-dimer level in the model, the Caprini score could more accurately predict the formation of DVT. Previously, the Caprini score combined with the D-dimer level showed higher predictive effectiveness in patients with thoracolumbar fractures caused by high-energy injuries [19]. We reached a similar conclusion that the AUC reached 0.865 after adding the D-dimer level to the Caprini ROC curve. When the Caprini score ≥ 10 and D-dimer > 0.835 μg/mL, the incidence of thrombosis was 38.7% (12/31), 16.7% in the IPC + LMWH group, and 69.2% in the IPC group (P < 0.01); thus, this group of patients needed the maximum amounts of prophylactic anticoagulants. Prolonged anticoagulants 4 weeks after laparoscopic colorectal cancer surgery can reduce the incidence of venous thrombosis from 9.7 to 0.9% [20]. We recommend that the drug prophylaxis be extended to 4 weeks for this group of patients.

Introducing D-dimer in thrombosis-related scoring system might be beneficial. The modified Geneva score and the Wells score are widely-used scoring system in pulmonary thrombosis [21]. Adding adjusted D-dimer level in the scoring system could improve the efficiency of the model [8, 21]. Adjusted D-dimer indicated high sensitivity for pulmonary thrombosis prediction, however, the specificity of D-dimer is low [8]. The unpromising specificity of D-dimer might limit its sole application in thrombosis prediction.

Of course, there are some limitations to our study. First, this is exploratory research. We were unable to preset the effect size and calculate the power of statistic in the study. Power analysis should be conducted in the future validation study. The effect size based on previous trails and the number of enrolled patients should be carefully designed. Second, the sample size of the single-center retrospective study was limited. Validation of the model based on Caprini and D-dimer in larger cohort should be done in the future. The study only performed internal verification; forward-looking experiments for external verification are still needed. The generalizability, reliability, and robustness of the model should be confirmed in diverse patient populations. Then, the potential false positive and false negative results of the model should be considered. False positive results might increase application of anti-coagulants drugs and potential bleeding risk. False negative results might increase risk of DVT for perioperative patients with CRC. Finally, the results of this study were only observed on the 6 (± 1) day postoperatively, excluding the occurrence of DVT after discharge. Actually, about 29% of DVT patients developed post-discharge thrombosis [22]. Delayed cases of DVT should not be neglected. Future studies of longer observation period should be done to provide a more comprehensive assessment of risk. Nonetheless, we improved the DVT predictive model based on Caprini score by introducing D-dimer, and provided more accurate stratification of DVT risk for patients with colorectal cancer. Different intervention methods should be considered for patients with different DVT risks.

Conclusion

The Caprini risk assessment model and D-dimer can provide more accurate risk stratification for patients after laparoscopic radical resection of colorectal cancer.

Acknowledgements

We would like to thank Bullet Edits for editing and polishing our manuscript.

Declarations

This study approved by the Ethics Committee of Xiangya Hospital, Central South University Hospital (No. 202112186). All patients in the cohort had signed informed consent.

Competing interests

The authors declare no competing interests.

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Siegel RL, Miller KD, Fuchs HE, Jemal A. Cancer Statistics, 2021. CA Cancer J Clin. 2021;71(1):7–33. https://doi.org/10.3322/caac.21654.CrossRefPubMed

Day ISCfWT. Thrombosis: a major contributor to the global disease burden. J Thromb Haemost. 2014;12(10):1580–90. https://doi.org/10.1111/jth.12698.

Bergqvist D. Venous thromboembolism: a review of risk and prevention in colorectal surgery patients. Dis Colon Rectum. 2006;49(10):1620–8. https://doi.org/10.1007/s10350-006-0693-0.CrossRefPubMed

Sakon M, Kobayashi T, Shimazui T. Efficacy and safety of enoxaparin in Japanese patients undergoing curative abdominal or pelvic cancer surgery: results from a multicenter, randomized, open-label study. Thromb Res. 2010;125(3):e65-70. https://doi.org/10.1016/j.thromres.2009.09.009.CrossRefPubMed

Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344–50. https://doi.org/10.1097/SLA.0b013e3181b7fca6.CrossRefPubMed

Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 Suppl):e227S-e277S. https://doi.org/10.1378/chest.11-2297.CrossRefPubMedPubMedCentral

Weitz JI, Fredenburgh JC, Eikelboom JW. A Test in Context: D-Dimer. J Am Coll Cardiol. 2017;70(19):2411–20. https://doi.org/10.1016/j.jacc.2017.09.024.CrossRefPubMed

Abolfotouh MA, Almadani K, Al Rowaily MA. Diagnostic accuracy of D-dimer testing and the revised geneva score in the prediction of pulmonary embolism. Int J Gen Med. 2020;13:1537–43. https://doi.org/10.2147/ijgm.S289289.CrossRefPubMedPubMedCentral

Stender MT, Frøkjaer JB, Hagedorn Nielsen TS, Larsen TB, Lundbye-Christensen S, Elbrønd H, et al. Combined use of clinical pre-test probability and D-dimer test in the diagnosis of preoperative deep venous thrombosis in colorectal cancer patients. Thromb Haemost. 2008;99(2):396–400. https://doi.org/10.1160/th07-06-0397.CrossRefPubMed

10.

Vickers AJ, van Calster B, Steyerberg EW. A simple, step-by-step guide to interpreting decision curve analysis. Diagn Progn Res. 2019;3:18. https://doi.org/10.1186/s41512-019-0064-7.CrossRefPubMedPubMedCentral

11.

Lu X, Zeng W, Zhu L, Liu L, Du F, Yang Q. Application of the Caprini risk assessment model for deep vein thrombosis among patients undergoing laparoscopic surgery for colorectal cancer. Medicine (Baltimore). 2021;100(4):e24479. https://doi.org/10.1097/MD.0000000000024479.

12.

Hata T, Yasui M, Ikeda M, Miyake M, Ide Y, Okuyama M, et al. Efficacy and safety of anticoagulant prophylaxis for prevention of postoperative venous thromboembolism in Japanese patients undergoing laparoscopic colorectal cancer surgery. Ann Gastroenterol Surg. 2019;3(5):568–75. https://doi.org/10.1002/ags3.12279.CrossRefPubMedPubMedCentral

13.

Pannucci CJ, Swistun L, MacDonald JK, Henke PK, Brooke BS. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients: a meta-analysis. Ann Surg. 2017;265(6):1094–103. https://doi.org/10.1097/SLA.0000000000002126.CrossRefPubMed

14.

Stein PD, Hull RD, Patel KC, Olson RE, Ghali WA, Brant R, et al. D-dimer for the exclusion of acute venous thrombosis and pulmonary embolism: a systematic review. Ann Intern Med. 2004;140(8):589–602. https://doi.org/10.7326/0003-4819-140-8-200404200-00005.CrossRefPubMed

15.

Liu DS, Stevens S, Wong E, Fong J, Mori K, Ward S, et al. Pre-operative and intra-operative chemical thromboprophylaxis increases bleeding risk following elective cholecystectomy: a multicentre (PROTECTinG) study. ANZ J Surg. 2020;90(12):2449–55. https://doi.org/10.1111/ans.15998.CrossRefPubMed

16.

Liu DS, Newbold R, Stevens S, Wong E, Fong J, Mori K, et al. Early versus postoperative chemical thromboprophylaxis is associated with increased bleeding risk following abdominal visceral resections: a multicenter cohort study. J Gastrointest Surg. 2022;26(7):1495–502. https://doi.org/10.1007/s11605-022-05301-4.CrossRefPubMedPubMedCentral

17.

investigators PR, collaborative V. Chemical thromboprophylaxis before skin closure increases bleeding risk after major ventral hernia repair: A multicenter cohort study. Surgery. 2022;172(1):198–204. https://doi.org/10.1016/j.surg.2022.01.023.

18.

Raskob GE, van Es N, Verhamme P, Carrier M, Di Nisio M, Garcia D, et al. Edoxaban for the treatment of cancer-associated venous thromboembolism. N Engl J Med. 2018;378(7):615–24. https://doi.org/10.1056/NEJMoa1711948.CrossRefPubMed

19.

Wang H, Lv B, Li W, Wang S, Ding W. Diagnostic performance of the Caprini risk assessment model combined with D-dimer for preoperative deep vein thrombosis in patients with thoracolumbar fractures caused by high-energy injuries. World Neurosurg. 2022;157:e410–6. https://doi.org/10.1016/j.wneu.2021.10.106.CrossRefPubMed

20.

Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R, et al. A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg. 2014;259(4):665–9. https://doi.org/10.1097/SLA.0000000000000340.CrossRefPubMed

21.

Stals MAM, Takada T, Kraaijpoel N, van Es N, Büller HR, Courtney DM, et al. Safety and efficiency of diagnostic strategies for ruling out pulmonary embolism in clinically relevant patient subgroups : a systematic review and individual-patient data meta-analysis. Ann Intern Med. 2022;175(2):244–55. https://doi.org/10.7326/m21-2625.CrossRefPubMed

22.

Davenport DL, Vargas HD, Kasten MW, Xenos ES. Timing and perioperative risk factors for in-hospital and post-discharge venous thromboembolism after colorectal cancer resection. Clin Appl Thromb Hemost. 2012;18(6):569–75. https://doi.org/10.1177/1076029611433642.CrossRefPubMed

Titel: Caprini risk assessment model combined with D-dimer to predict the occurrence of deep vein thrombosis and guide intervention after laparoscopic radical resection of colorectal cancer
verfasst von: Wuming Zhang
Ruizheng Sun
Xianqin Hu
Zhikang Chen
Chen Lai
Publikationsdatum: 01.12.2023
Verlag: BioMed Central
Erschienen in: World Journal of Surgical Oncology / Ausgabe 1/2023
Elektronische ISSN: 1477-7819
DOI: https://doi.org/10.1186/s12957-023-03183-7

Neu im Fachgebiet Chirurgie

Vorsicht, erhöhte Blutungsgefahr nach PCI!

10.05.2024 Koronare Herzerkrankung Nachrichten

Nach PCI besteht ein erhöhtes Blutungsrisiko, wenn die Behandelten eine verminderte linksventrikuläre Ejektionsfraktion aufweisen. Das Risiko ist umso höher, je stärker die Pumpfunktion eingeschränkt ist.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Deutlich weniger Infektionen: Wundprotektoren schützen!

08.05.2024 Postoperative Wundinfektion Nachrichten

Der Einsatz von Wundprotektoren bei offenen Eingriffen am unteren Gastrointestinaltrakt schützt vor Infektionen im Op.-Gebiet – und dient darüber hinaus der besseren Sicht. Das bestätigt mit großer Robustheit eine randomisierte Studie im Fachblatt JAMA Surgery.

Chirurginnen und Chirurgen sind stark suizidgefährdet

07.05.2024 Suizid Nachrichten

Der belastende Arbeitsalltag wirkt sich negativ auf die psychische Gesundheit der Angehörigen ärztlicher Berufsgruppen aus. Chirurginnen und Chirurgen bilden da keine Ausnahme, im Gegenteil.

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Aktuelle BDC Leitlinien-Webinare

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare

CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare

CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske

Dr. med. Benjamin Meyknecht

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare

CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric

Springer Medizin

Abstract

Background

Methods

Results

Conclusions

Publisher’s Note

Background

Materials and methods

Patients and design

Data collection

Data analysis

Results

Basic data

Caprini risk assessment and D-dimer test were independent risk factors for DVT in the IPC group

Models based on Caprini risk assessment and D-dimer showed great discrimination of DVT in the IPC group

The model based on Caprini score and D-dimer was reliable in the whole cohort

Clinical decisions based on the model of Caprini score and D-dimer might benefit for patients

Discussion

Conclusion

Acknowledgements

Declarations

Ethics approval and consent to participate

Competing interests

Publisher’s Note

Weitere Artikel der Ausgabe 1/2023

Correction: Clinicopathologic and mutational profiles of primary breast diffuse large B cell lymphoma in a male patient: case report and literature review

Long-term outcomes after cytoreductive nephrectomy and thrombectomy of patients with metastatic renal cell carcinoma with venous tumor thrombus: a retrospective study from a large Chinese center

GREM1 is a potential biomarker for the progression and prognosis of bladder cancer

Quantitative dynamic contrast-enhance MRI parameters for rectal carcinoma characterization: correlation with tumor tissue composition

Internal jugular vein reconstruction using a triple-paneled great saphenous vein graft

Different lymph node dissection ranges during radical prostatectomy for patients with prostate cancer: a systematic review and network meta-analysis

Update Chirurgie